Get Harrow alerts:Harrow, Inc. (NASDAQ:HROW – Free Report) – Equities researchers at B. Riley cut their Q4 2025 earnings estimates for Harrow in a research note issued to investors on Tuesday, September 30th. B. Riley currently has a “Buy” rating and a $74.00 price target on the stock. Zacks Research downgraded Harrow from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 12th. BTIG Research reiterated a “buy” rating and set a $63.00 price objective on shares of Harrow in a research report on Wednesday, September 24th. Harrow Company Profile(Get Free Report)Harrow, Inc operates as an ophthalmic-focused healthcare company.